🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
No one really knows what causes overactive bladder syndrome (OAB). Urinary ...
Status
Completed
Location
Loyola University Chicago Health Sciences Division
Start Date
2012-07
Trial ID
NCT01642277
Treatments Being Tested
The primary objective of this prospective, single-centre randomized control...
Status
Unknown
Location
Urology and Nephrology Center
Start Date
2021-12-01
Trial ID
NCT04325880
Treatments Being Tested
A randomized controlled study to compare the efficacy of mirabegron, solife...
Status
Unknown
Location
Urology and Nephrology Center, Mansoura University
Start Date
2022-03-01
Trial ID
NCT05490082
Treatments Being Tested
The purpose of this study was to see if adding a new type of medication rec...
Status
Completed
Location
Genova Clinical Research
Start Date
2013-07-10
Trial ID
NCT01908829
This single-dose study will investigate how well solifenacin suspension is ...
Status
Completed
Location
Multiple Locations
Start Date
2010-10-20
Trial ID
NCT01262391
The purpose of this study is to determine if pelvic surgery can improve urg...
Status
Unknown
Location
Abt. Beckenbodenchirugie der Universitäts-Frauenklinik Köln
Start Date
2013-01
Trial ID
NCT01737411
Treatments Being Tested
The investigators will compare the efficacy and safety of tadalafil/solifen...
Status
Unknown
Location
Urology and Nephrology center
Start Date
2021-11-08
Trial ID
NCT05494567
Treatments Being Tested
To assess the effect of fesoterodine 8 mg as compared to solifenacin 10 mg ...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-04
Trial ID
NCT00832650
Treatments Being Tested
The purpose is to see if solifenacin has any effect on bladder wall thickne...
Status
Completed
Location
Multiple Locations
Start Date
2010-01-19
Trial ID
NCT01093534
Treatments Being Tested
Botulinum toxin type A injections into the detrusor at a dose of 200 units ...
Status
Terminated
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2021-06-01
Trial ID
NCT04819360
Treatments Being Tested